BCEIE › News › BAYERCROP

Management change

Bayer Cropscience: Please be informed that the Board of Directors at the meeting held on November 03, 2026 took note of the…

Bayer Cropscience (BAYERCROP) filed a disclosure titled "Please be informed that the Board of Directors at the meeting held on November 03, 2026 took note of the changes in Directors". The company is valued at about ₹14,738 crore.

BCEIE News Desk · Published 3 Nov 2026, 07:27 pm IST · Filing received 3 Nov 2026, 07:12 pm IST

What happened

Bayer Cropscience (BAYERCROP) filed a disclosure with the exchanges on 3 November 2026 at 07:12 PM titled "Please be informed that the Board of Directors at the meeting held on November 03, 2026 took note of the changes in Directors".

Company snapshot

Bayer Cropscience is a small-cap company in the Chemicals sector, with a market value of about ₹14,738 crore.

The stock last traded at ₹3,279.4, against a 52-week range of ₹3,240–₹5,063 (35.2% below the high).

Before this filing the shares had moved −9.6% over the month and −23.8% over three months. Average daily turnover over the last 20 sessions was about ₹9.79 crore.

Promoters held 71.43% at the end of Q1 FY27. Foreign institutions owned 3.97% and domestic institutions 11.64%.

Quarterly results (standalone, ₹ crore)
QuarterRevenueNet profitEPS (₹)
Q1 FY261,915278.762.01
Q2 FY261,553152.733.98
Q3 FY261,10695.721.29
Q4 FY261,101162.136.07
Q1 FY271,835321.671.56

What history shows

This is not the company's first management change disclosure: BCEIE has 1 earlier filing of this kind on record since May 2026.

Across 73 similar disclosures by other Chemicals companies, shares moved −0.3% on average the next day and +0.2% over five days; 45% of them rose the next day.

Market-wide, 4,129 management change filings with an impact score of 50 or more saw an average next-day move of −0.1%, with 44% rising.

Past reactions describe what happened before; they are not a forecast.

What to watch

  • The appointment of a successor and any change in strategy or guidance.

In the news

Recent coverage elsewhere (links open the original publisher):

Source

Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.

More on Bayer Cropscience Limited